Article

Eliciting tamsulosin treatment history key for predicting IFIS

Intraoperative floppy iris syndrome (IFIS) can result in a high complication rate when unanticipated, but with a simple preoperative medication history, cataract surgeons can now predict when this problem may occur, said David F. Chang, MD, in the ?Spotlight on Cataract Surgery 2005? session held during the annual meeting of the American Academy of Ophthalmology.

Chicago-Intraoperative floppy iris syndrome (IFIS) can result in a high complication rate when unanticipated, but with a simple preoperative medication history, cataract surgeons can now predict when this problem may occur, said David F. Chang, MD, in the “Spotlight on Cataract Surgery 2005” session held during the annual meeting of the American Academy of Ophthalmology.

IFIS is characterized by the clinical triad of initial billowing and flopping of the iris in response to normal irrigation currents in the anterior chamber, repeated iris prolapse to the incisions, and progressive miosis.

Based on retrospective observations, John Campbell, MD, first related IFIS to patient use of the alpha-1a selective adrenoreceptor antagonist tamsulosin (FloMax, Boehringer Ingelheim). Subsequent studies by Dr. Campbell and Dr. Chang corroborated that association and showed that IFIS was associated with a high rate of posterior capsular rupture. Their experience also indicated that traditional methods for managing small pupils, including partial thickness sphincterotomies and mechanical pupil stretching, were ineffective in eyes with IFIS.

Alternatives that have been found useful for maintaining pupil dilation and blocking iris prolapse to the incision include viscomydriasis with Healon 5 (AMO), use of ophthalmic viscosurgical devices in an ultra-soft shell technique, insertion of pupil expansion rings, and placement of iris retractors in a diamond configuration.

Now preliminary results of a multicenter prospective trial involving 169 consecutive patients currently on tamsulosin show promise that good outcomes are possible when at-risk patients are identified preoperatively and appropriate intraoperative strategies are employed.

“Tamsulosin is the most commonly prescribed drug in the United States for treating men with benign prostatic hypertrophy, and so it is important that cataract surgeons be aware of this new syndrome of IFIS,” Dr. Chang said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.